The major merozoite surface protein as a malaria vaccine target.
about
Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responsesBlood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.Genetic diversity among Plasmodium falciparum field isolates in Pakistan measured with PCR genotyping of the merozoite surface protein 1 and 2.Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malariaProtection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines.Current status of malaria and potential for control.Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands.Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogensNaturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro.Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infectionMalaria vaccines in development.Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.A new rodent model to assess blood stage immunity to the Plasmodium falciparum antigen merozoite surface protein 119 reveals a protective role for invasion inhibitory antibodiesImmunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.Molecular genetic characterization of the merozoite surface protein 1 Gene of Plasmodium vivax from reemerging Korean isolates.Isolation and Characterization of Vaccine Candidate Genes Including CSP and MSP1 in Plasmodium yoelii.Plasmodium falciparum rhoptry proteins of 140/130/110 kd (Rhop-H) are located in an electron lucent compartment in the neck of the rhoptries.CD36 c.1264 T>G null mutation impairs acquisition of IgG antibodies to Plasmodium falciparum MSP1₁₉ antigen and is associated with higher malaria incidences in Tanzanian children.Genetic diversity of Plasmodium falciparum merozoite surface protein-1 (block 2), glutamate-rich protein and sexual stage antigen Pfs25 from Chandigarh, North India.Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro.
P2860
Q33264523-E1BC0155-729A-4279-A735-8256DD424747Q33356029-2EC15467-8CC9-443F-AC9F-B33511EC7C76Q33415066-47069AD9-2095-4EA0-8609-C70138D8D13AQ33590165-4BC0DA67-6F7C-4D0F-9337-78F86919FF0AQ33752297-FDCFE9CA-C772-40BA-8505-4BF7BF057C05Q33757015-B125CA34-2142-4D28-8546-87ADCA1655C0Q33975652-62C9CD75-FBA4-48B4-9E3E-68469767B798Q34180495-163D9EFF-25B8-4A25-B419-B9EC0FA08A7FQ34401573-0C622237-E4D0-4C59-8B41-9124D0145B69Q34541366-3E2E6456-D3B9-4C21-AB20-32154BD83ACAQ35516848-07E3B5A7-522D-423C-B670-971605BC2B55Q36219634-40B729C2-6385-49BC-BA48-AF0FCA941B0FQ36368911-6CEFDB14-3C54-475C-B8A2-BD11A1244536Q36371697-3C1B69E2-9821-4AA3-9CB8-BFB95DCDF68CQ36437429-6EA84024-944C-46E0-8FE3-08C280BB6DBFQ37867102-04EA51A4-63AD-4FF1-81FC-A506153CF94DQ38496153-4D34CE80-20A7-4688-8B17-EF84C7365CD2Q40129832-AA226F2E-2D0F-49D3-871C-5EB7D9B6DC84Q42673110-01D48E74-DA36-4ECB-AF99-59423B5F8F68Q43939727-86F2A144-7EB2-429F-8224-38A5D4EF5315Q46286513-0D77937E-587E-41A6-8BED-5243A548D3C8Q47845842-B0F88260-0203-4422-B329-1903619B28EA
P2860
The major merozoite surface protein as a malaria vaccine target.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
The major merozoite surface protein as a malaria vaccine target.
@en
The major merozoite surface protein as a malaria vaccine target.
@nl
type
label
The major merozoite surface protein as a malaria vaccine target.
@en
The major merozoite surface protein as a malaria vaccine target.
@nl
prefLabel
The major merozoite surface protein as a malaria vaccine target.
@en
The major merozoite surface protein as a malaria vaccine target.
@nl
P1476
The major merozoite surface protein as a malaria vaccine target.
@en
P2093
P304
P356
10.1016/0169-4758(93)90130-8
P577
1993-08-01T00:00:00Z